Washington Trust Advisors, Inc. Haemonetics Corp Transaction History
Washington Trust Advisors, Inc.
- $1.19 Billion
- Q2 2025
A detailed history of Washington Trust Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 129 shares of HAE stock, worth $6,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129
Previous 129
-0.0%
Holding current value
$6,419
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
336Shares Held
53.5MCall Options Held
540KPut Options Held
306K-
Black Rock Inc. New York, NY5.96MShares$297 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$246 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$213 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$107 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$93.7 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.55B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...